Induction of CYP2C19 1,4
Based on in vitro assessment, luliconazole at therapeutics doses, particularly when applied to patients with moderate to severe tinea cruris, may inhibit the activity of CYP2C19; however no in vivo drug interaction trials have been conducted to evaluate the effect of luliconazole on drugs that are substrates of CYP2C19.